BamSEC and AlphaSense Join Forces
Learn More

Dance Biopharm Inc.

Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.15
from S-1/A 26 pages Master Manufacturing Agreement for Medical Products / Finished Device Assembly [*] Insulin Inhaler
12/34/56
EX-10.13
from S-1/A 56 pages Confidential License, Development, Collaboration, and Commercialization Agreement by and Between Dance Pharmaceuticals, Inc. and Aerogen Limited November 2010
12/34/56
EX-10.10
from S-1/A 14 pages Employment Agreement
12/34/56
EX-10.9
from S-1/A 14 pages Employment Agreement
12/34/56
EX-10.8
from S-1/A 14 pages Employment Agreement
12/34/56
EX-10.7
from S-1/A 14 pages Employment Agreement
12/34/56
EX-10.25
from S-1 23 pages Phase 3 Clinical and Commercial Supply Agreement
12/34/56
EX-10.24
from S-1 23 pages Background
12/34/56
EX-10.23
from S-1 17 pages Manufacturing Agreement
12/34/56
EX-10.22
from S-1 24 pages Background
12/34/56
EX-10.21
from S-1 55 pages Office Lease (Gross) 150 North Hill Drive, Brisbane, Ca
12/34/56
EX-10.20
from S-1 2 pages Material contract
12/34/56
EX-10.19
from S-1 13 pages Dance Pharmaceuticals, Inc. Warrant to Purchase Common Stock
12/34/56
EX-10.18
from S-1 13 pages Dance Pharmaceuticals, Inc. Warrant to Purchase Common Stock
12/34/56
EX-10.17
from S-1 41 pages License, Supply and Manufatcuring Agreement
12/34/56
EX-10.16
from S-1 24 pages Master Agreement for Joint Venture in Asia
12/34/56
EX-10.15
from S-1 26 pages Master Manufacturing Agreement for Medical Products / Finished Device Assembly [*] Insulin Inhaler
12/34/56
EX-10.14
from S-1 34 pages Addendum 1 to the License, Development, Collaboration and Commercialization Agreement Commercial Supply Agreement for Device Proprietary Components
12/34/56
EX-10.13
from S-1 56 pages Confidential License, Development, Collaboration, and Commercialization Agreement by and Between Dance Pharmaceuticals, Inc. and Aerogen Limited November 2010
12/34/56
EX-10.11
from S-1 17 pages Warrant Agreement to Purchase Shares of Preferred Stock of Dance Biopharm, Inc. Dated as of October 30, 2013
12/34/56